 - Patients who withdrew from one of the qualifying studies i.e. patient previously took part in an Amgen study investigating the drug AMG 073 and its effects on secondary hyperparathyroidism HPT; in particular parathyroid hormone PTH, calcium and phosphorus levels in blood associated with kidney failure due to kidney transplantation. 